Latest On Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-11-20 05:00 EST | Dividend | A dividend of $0.57 has been announced on Nov 7, 2023. It will be paid Nov 22, 2023 with an ex-dividend date of Nov 20, 2023. | Neutral |  |
| 2023-05-22 06:00 EST | Dividend | A dividend of $0.6 has been announced on Mar 16, 2023. It will be paid May 24, 2023 with an ex-dividend date of May 22, 2023. | Neutral | |
| 2023-05-14 12:53 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-11 13:50 EST | News | Recordati GAAP EPS of €0.59, revenue of €551.4M | N/A | |
| 2023-05-11 13:50 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-02-25 15:15 EST | News | Recordati Industria Chimica E Farmaceutica S.p.A. (RCDTF) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-21 19:16 EST | News | Recordati reports FY results; initiates FY23 and FY25 guidance | N/A | |
| 2022-11-21 05:00 EST | Dividend | A dividend of $0.55 has been announced on Nov 17, 2022. It will be paid Nov 23, 2022 with an ex-dividend date of Nov 21, 2022. | Neutral | |
| 2022-11-12 15:32 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-08 23:14 EST | News | Recordati GAAP EPS of €1.15, revenue of €1.38B | N/A | |
| 2022-07-31 01:30 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-07-28 17:51 EST | News | Recordati GAAP EPS of €0.72, revenue of €892.49M | N/A | |
| 2022-05-23 06:00 EST | Dividend | A dividend of $0.57 has been announced on May 2, 2022. It will be paid May 25, 2022 with an ex-dividend date of May 23, 2022. | Neutral | |
| 2022-05-15 03:36 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-02-25 18:47 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-25 01:25 EST | News | Recordati reports FY results | N/A | |
| 2022-02-25 01:25 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-11-22 05:01 EST | Dividend | A dividend of $0.53 has been announced on Nov 17, 2021. It will be paid Nov 24, 2021 with an ex-dividend date of Nov 22, 2021. | Neutral | |
| 2021-10-31 15:28 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-29 10:41 EST | News | Recordati reports Q3 results | N/A | |
| 2021-10-29 10:41 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-08-01 13:41 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-05-24 06:03 EST | Dividend | A dividend of $0.55 has been announced on Mar 23, 2021. It will be paid May 26, 2021 with an ex-dividend date of May 24, 2021. | Neutral | |
| 2021-02-27 22:52 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-26 09:09 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-22 13:38 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2020-11-26 23:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-23 05:02 EST | Dividend | A dividend of $0.5 has been announced on Nov 19, 2020. It will be paid Nov 25, 2020 with an ex-dividend date of Nov 23, 2020. | Neutral | |
| 2020-11-08 02:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 05:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-01 08:51 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-09-26 15:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-19 00:35 EST | News | Recordati Industria Chimica e Farmaceutica S (RCDTF) Investor Presentation - Slideshow) | N/A | |
| 2020-09-17 07:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-03 06:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-02 06:46 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-02 06:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:57 EST | News | Recordati Industria Chimica e Farmaceutica S.p.A. 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-07-30 19:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 10:53 EST | News | Recordati reports 1H results | N/A | |
| 2020-07-30 07:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:51 EST | Financials | Company financials have been released. | Neutral | |
About Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF):
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, cosmetics, dermatology, dietary supplements, gynecology and obstetrics, medical devices, musculo-skeletal disorders and analgesia, over the counter/non-prescription pharmaceuticals, urology, allergy, anti-infectives, central nervous system, endocrinology, gastrointestinal, nutrition and related products, pain management/inflammation, generics, pneumology, antipyretics and cold preparations, endocrinology, oncology, respiratory, and medical devices, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Fimei - Finanziaria Industriale Mobiliare ed Immobiliare S.P.A.
General
- Name Recordati Industria Chimica e Farmaceutica S.p.A
- Symbol RCDTF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-General
- Full Time Employees 4,300
- Fiscal Year EndDecember
- Web URLhttp://www.recordati.com
View More
Valuation
- Trailing PE 24.92
- Forward PE 21.98
- Price/Sales (Trailing 12 Mt.) 6.38
- Price/Book (Most Recent Quarter) 7.19
- Enterprise Value Revenue 8.15
- Enterprise Value EBITDA 21.11
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 25%
- Return on Assets 11%
- Return on Equity 29%
- Revenue Per Share $0
- Gross Profit 1.04 billion
- Quarterly Earnings Growth -6.9%
View More
ESG Rating
Highlights
- Market Capitalization 11.01 billion
View More
Share Statistics
- Shares Outstanding 203.97 million
- Shares Float 99.12 million
- % Held by Insiders 5182%
- % Held by Institutions 28.64%
View More
Technicals
- Beta 0.13
- 52 Week High $55.87
- 52 Week Low $37.26
- 50 Day Moving Average 52.93
- 200 Day Moving Average 53.74
View More
Dividends
- Forward Annual Dividend Rate $1.19
- Forward Annual Dividend Yield 2.22%
- Payout Ratio 80%
- Dividend Date N/A
- ExDividend Date 2020-11-23
- Dividend Per Share $1.19
- Dividend Yield 0%
View More
Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF) Dividend Calendar:
Recordati Industria Chimica e Farmaceutica S.p.A pays out 80% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-10-29 | $N/A | $0.37 | $0.45 | -17.78% |
| 2020-06-30 | 2020-09-30 | $330.96 million | $0.44 | $0.47 | -6.38% |
| 2020-03-31 | 2020-06-30 | $N/A | $0.47 | $0.45 | 4.24% |
| 2019-12-31 | 2020-03-31 | $381.43 million | $0.59 | $0.37 | 58.46% |
| 2019-09-30 | 2019-12-31 | $357.17 million | $0.62 | $0.38 | 62.66% |
| 2019-06-30 | 2019-09-30 | $360.26 million | $0.42 | $0.40 | 5.68% |
| 2019-03-31 | 2019-06-30 | $382.99 million | $0.46 | $0.42 | 8.86% |
| 2018-12-31 | 2019-03-31 | $338.93 million | $0.49 | $0.34 | 45.18% |
| 2018-09-30 | 2018-12-31 | $317.25 million | $0.41 | $0.38 | 7.61% |
| 2018-06-30 | 2018-09-30 | $329.55 million | $0.42 | $0.37 | 13% |
| 2018-03-31 | 2018-06-30 | $366.5 million | $0.44 | $0.40 | 10.45% |
| 2017-12-31 | 2018-03-31 | $324.3 million | $0.51 | $0.35 | 45.71% |
| 2017-09-30 | 2017-12-31 | $312.96 million | $0.40 | $0.33 | 19.97% |
| 2017-06-30 | 2017-09-30 | $308.93 million | $0.42 | $0.34 | 22.5% |
| 2017-03-31 | 2017-06-30 | $0.38 | $0.33 | 15.03% | |
| 2016-12-31 | 2017-03-31 | $0.40 | $0.28 | 42.89% | |
| 2016-09-30 | 2016-12-31 | $0.28 | $0.25 | 10.76% | |
| 2016-06-30 | 2016-09-30 | $0.33 | $0.30 | 8.4% | |
| 2016-03-31 | 2016-06-30 | $0.31 | $0.26 | 19.08% | |
| 2015-12-31 | 2016-03-31 | $0.36 | $0.23 | 55% | |
| 2015-09-30 | 2015-12-31 | $0.24 | $0.25 | -3.56% | |
| 2015-06-30 | 2015-09-30 | $0.27 | $0.23 | 16.52% | |
| 2015-03-31 | 2015-06-30 | $0.28 | |||
| 2014-12-31 | 2015-03-31 | $0.27 | |||
| 2014-09-30 | 2014-12-31 | $0.22 | |||
| 2014-06-30 | 2014-09-30 | $0.25 | |||
| 2014-03-31 | 2014-06-30 | $0.27 | |||
| 2013-12-31 | 2014-03-31 | $0.28 | |||
| 2013-09-30 | 2013-12-31 | $0.21 | |||
| 2013-06-30 | 2013-09-30 | $0.21 | |||
| 2013-03-31 | 2013-06-30 | $0.21 | |||
| 2012-12-31 | 2013-03-31 | $0.23 | |||
| 2012-09-30 | 2012-12-31 | $0.16 | |||
| 2012-06-30 | 2012-09-30 | $0.19 | |||
| 2012-03-31 | 2012-06-30 | $0.19 | |||
| 2011-12-31 | 2012-03-31 | $0.22 | |||
| 2011-09-30 | 2011-12-31 | $0.15 | |||
| 2011-06-30 | 2011-09-30 | $0.20 | |||
| 2011-03-31 | 2011-06-30 | $0.23 | |||
| 2010-12-31 | 2011-03-31 | $0.21 | |||
| 2010-09-30 | 2010-12-31 | $0.14 | |||
| 2010-06-30 | 2010-06-30 | $0.18 | |||
| 2010-03-31 | 2010-03-31 | $0.20 | |||
| 2009-12-31 | 2009-12-31 | $0.18 |
Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | 36.31 million | N/A | 38.1 million |
| Income Before Tax | N/A | N/A | 108.9 million | N/A | 106.62 million |
| Selling General Administrative | N/A | N/A | 92.66 million | N/A | 120.25 million |
| Gross Profit | N/A | N/A | 244.71 million | N/A | 273.6 million |
| Ebit | N/A | N/A | 136.24 million | N/A | 110.83 million |
| Operating Income | N/A | N/A | 117.04 million | N/A | 110.83 million |
| Income Tax Expense | 35.26 million | 21.26 million | 23.15 million | 34.34 million | -8.57 million |
| Total Revenue | N/A | N/A | 330.96 million | N/A | 381.43 million |
| Cost of Revenue | N/A | N/A | 86.24 million | N/A | 107.83 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -4.21 million |
| Net Income From Continuing Operations | N/A | N/A | 85.75 million | N/A | 115.19 million |
| Net Income Applicable to Common Shares | 80.94 million | 77.15 million | 85.75 million | 111.18 million | 115.18 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -9.74 million | -69.64 million | N/A | N/A | N/A |
| Change to Liabilities | -19.86 million | N/A | N/A | N/A | -6.74 million |
| Total Cash Flow from Investing Activities | -9.74 million | N/A | N/A | N/A | -23.45 million |
| Net Borrowings | -34.83 million | N/A | N/A | N/A | 396.77 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | 399.92 million |
| Change to Operating Activities | 3.46 million | N/A | N/A | N/A | -2.57 million |
| Change in Cash | 35.85 million | 25.44 million | N/A | N/A | 509.69 million |
| Total Cash from Operating Activities | 69.95 million | 113.16 million | N/A | N/A | 122.42 million |
| Depreciation | 23.96 million | 23.19 million | N/A | N/A | 19.36 million |
| Other Cash Flow from Investing Activities | -36000 | N/A | N/A | N/A | -113000 |
| Change to Inventory | -15.15 million | -30.55 million | N/A | N/A | -6.41 million |
| Change to Account Receivables | N/A | N/A | N/A | N/A | 19.88 million |
| Other Cash Flow from Financing Activities | 3.76 million | N/A | N/A | N/A | -3.26 million |
| Change to Net Income | 1.22 million | N/A | N/A | N/A | 5.3 million |
| Capital Expenditures | 9.7 million | 69.49 million | N/A | N/A | 7.31 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 1.57 billion | N/A | 1.61 billion |
| Total Stockholder Equity | N/A | N/A | 1.24 billion | N/A | 1.2 billion |
| Other Current Liabilities | N/A | 124.95 million | 10.94 million | N/A | 237.28 million |
| Total Assets | N/A | N/A | 2.81 billion | N/A | 2.81 billion |
| Common Stock | N/A | 26.14 million | 26.14 million | 26.14 million | 26.14 million |
| Other Current Assets | N/A | 24.09 million | 10.3 million | N/A | 17.63 million |
| Retained Earnings | N/A | 1.43 billion | 1.35 billion | 1.38 billion | 1.27 billion |
| Other Liabilities | N/A | 81.71 million | 83.55 million | 83.75 million | 86.02 million |
| Other Assets | N/A | 84.82 million | 92.62 million | 85.45 million | 87.94 million |
| Cash | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | 541.89 million | 512.61 million | N/A | 586.75 million |
| Other Stockholder Equity | N/A | -155.56 million | -116.09 million | -112.03 million | -87.57 million |
| Property, Plant & Equipment | N/A | 129.74 million | 131.53 million | 130.42 million | 133.34 million |
| Total Current Assets | N/A | 879.16 million | 840.27 million | N/A | 809.35 million |
| Long Term Investments | N/A | N/A | N/A | N/A | 38.57 million |
| Net Tangible Assets | -351.76 million | -400.19 million | -472.46 million | -485.24 million | -541.16 million |
| Short Term Investments | N/A | N/A | 218.39 million | N/A | 187.92 million |
| Long Term Debt | N/A | N/A | N/A | N/A | 937.34 million |
| Inventory | N/A | 250.33 million | 255.1 million | N/A | 226.89 million |
| Accounts Payable | N/A | 145.2 million | 155.59 million | N/A | 175.48 million |
Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF) Chart:
Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF) News:
Below you will find a list of latest news for Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|